Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Suzuken Co ( (JP:9987) ) has shared an update.
Suzuken Co., Ltd. announced the results of its share repurchase program for November 2025, where it repurchased 471,900 common shares for approximately ¥2.77 billion. This activity is part of a larger repurchase plan initiated in May 2025, aiming to buy back up to 5.2 million shares by March 2026, reflecting the company’s strategy to enhance shareholder value.
The most recent analyst rating on (JP:9987) stock is a Buy with a Yen6800.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the pharmaceutical industry, focusing on the distribution of pharmaceuticals and medical devices. The company is traded on the Prime Markets of the Tokyo and Nagoya Stock Exchanges, and the Sapporo Securities Exchange.
YTD Price Performance: 30.67%
Average Trading Volume: 185,400
Technical Sentiment Signal: Buy
Current Market Cap: Yen344.9B
For an in-depth examination of 9987 stock, go to TipRanks’ Overview page.